INTRODUCTION: Dexmedetomidine is a centrally acting alpha(2)-adrenergic agonist which is currently FDA-approved for the short-term (less than 24 h) sedation of adults during mechanical ventilation. DISCUSSION: Given its beneficial physiologic properties, there has been increasing use of this agent in the pediatric population. As with any agent used for sedation in the Pediatric ICU setting, dose escalations may be necessary. Unlike benzodiazepines and opioids, there are limited data regarding the administration of dexmedetomidine above the current package insert dosing recommendations of 0.7 microg/kg/h. RESULTS: We report a 2-year-old child with traumatic brain injury who developed hypertension following the administration of a dexmedetomidine infusion at 4 microg/kg/h for several hours. Investigation into the etiology of the hypertension was negative and the blood pressure returned to baseline with a decrease in the infusion rate. CONCLUSION: Subsequent to this, no further issues with hypertension were noted.
INTRODUCTION:Dexmedetomidine is a centrally acting alpha(2)-adrenergic agonist which is currently FDA-approved for the short-term (less than 24 h) sedation of adults during mechanical ventilation. DISCUSSION: Given its beneficial physiologic properties, there has been increasing use of this agent in the pediatric population. As with any agent used for sedation in the Pediatric ICU setting, dose escalations may be necessary. Unlike benzodiazepines and opioids, there are limited data regarding the administration of dexmedetomidine above the current package insert dosing recommendations of 0.7 microg/kg/h. RESULTS: We report a 2-year-old child with traumatic brain injury who developed hypertension following the administration of a dexmedetomidine infusion at 4 microg/kg/h for several hours. Investigation into the etiology of the hypertension was negative and the blood pressure returned to baseline with a decrease in the infusion rate. CONCLUSION: Subsequent to this, no further issues with hypertension were noted.
Authors: Constantinos Chrysostomou; Sylvie Di Filippo; Ana-Maria Manrique; Carol G Schmitt; Richard A Orr; Alfonso Casta; Erin Suchoza; Janine Janosky; Peter J Davis; Ricardo Munoz Journal: Pediatr Crit Care Med Date: 2006-03 Impact factor: 3.624
Authors: Gregory B Hammer; David R Drover; Hong Cao; Ethan Jackson; Glyn D Williams; Chandra Ramamoorthy; George F Van Hare; Alisa Niksch; Anne M Dubin Journal: Anesth Analg Date: 2008-01 Impact factor: 5.108
Authors: Keira P Mason; David Zurakowski; Steven E Zgleszewski; Caroline D Robson; Maureen Carrier; Paul R Hickey; James A Dinardo Journal: Paediatr Anaesth Date: 2008-03-18 Impact factor: 2.556
Authors: Richard C Prielipp; Michael H Wall; Joseph R Tobin; Leanne Groban; Mark A Cannon; Frederic H Fahey; H Donald Gage; David A Stump; Robert L James; Judy Bennett; John Butterworth Journal: Anesth Analg Date: 2002-10 Impact factor: 5.108